[PDF] Top 20 Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer
Has 10000 "Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer" found on our website. Below are the top 20 most common "Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer".
Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer
... of compounds, including the presence of a stem cell phenotype, the activation of polo-like kinase 1 (PLK1), or the basal activity of intracellular signaling kinases like protein kinase B (AKT) or ... See full document
9
Targeting of prostate specific membrane antigen for radio ligand therapy of triple negative breast cancer
... the cancer cell mobility and invasiveness, as described for the prostate cancer cells [46, ...dipeptidase activity, PSMA generates glutamate, which is efficiently taken up by the glutamate auxotroph ... See full document
11
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
... suggests a causal relationship between the F1 antitumor response and NK cell activation. In agreement, IL-15 mRNA level was inversely correlated with tumor volume in the entire population (three groups together) by ... See full document
17
Original Article miR-504 regulates chemosensitivity in triple negative breast cancer (TNBC) cells via targeting ABCB8
... miR-504 directly targets the 3’UTR of ABCB8 and regulates its expression in TNBC cells ABCB8 was identified as a putative target of miR-504 using miRNA target prediction pro- gram miR and a (www.microrna.org). To vali- ... See full document
8
Triple negative breast cancer
... anti-tumor activity in several preclinical studies with breast cancer models, both alone or in combination with chemo- therapeutic ...HER2- negative advanced breast cancer ... See full document
9
Immunotherapeutic interventions of Triple Negative Breast Cancer
... expressing cancer cells by internalizing and trafficking to the lyso- some ...most breast cancers and promotes metastases by mediating intercellular adhe- sion, promoting tissue repair, regulating cell ... See full document
19
Metformin overcomes resistance to cisplatin in triple negative breast cancer (TNBC) cells by targeting RAD51
... anti- cancer effects of metformin under reduced glucose were more pronounced in MDA-MB-231 than HS-578T ...most cancer cell ...biological activity in a 4T1 mouse breast cancer model in ... See full document
18
Targeting triple negative breast cancer cells with the histone deacetylase inhibitor panobinostat
... potent activity at low nanomolar concentrations across a wide range of hema- tologic malignancies and solid tumors in preclinical stu- dies ...resensitizing cancer cells to other agents including ... See full document
15
LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
... ligase activity, ion binding, transition metal ion binding, small conjugation protein ligase activity, metal ion binding, and RNA ...binding activity and ligase activity, which means these ... See full document
13
Targeting FOSB with a cationic antimicrobial peptide, TP4, for treatment of triple-negative breast cancer
... but were not statistically different to NAT (Figure 3A). These results indicate that FOSB expression is decreased during TNBC progression, and suggest that FOSB may be detrimental to TNBC development. We then evaluated ... See full document
19
MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer
... TNBC cells were exposed to different doses of ionizing radiation. The TNBC cells were continued to culture for 24 h, the caspase-Glo3/7 assay kit (Promega, Madison, USA) was used to examine apoptosis activity by ... See full document
10
Novel therapeutic strategies for patients with triple-negative breast cancer
... has activity responses in patients with high-grade serous cancer without germline BRCA1 or BRCA2 mutations, which has illustrated that olaparib is a promising therapeutic option for women with these ... See full document
10
MiR-33a functions as a tumor suppressor in triple-negative breast cancer by targeting EZH2
... In breast cancer, its expression was correlated with breast cancer aggressiveness and could serve as an independent pre- dictor of survival and recurrence ...miR-21 activity and ... See full document
12
Targeting the androgen receptor in triple-negative breast cancer: current perspectives
... Abstract: Triple-negative breast cancer (TNBC) is an aggressive subtype associated with frequent recurrence and ...normal breast development, and its dysregulation has been implicated ... See full document
11
Targeting triple-negative breast cancer cells using Dengue virus-mimicking pH-responsive framboidal triblock copolymer vesicles
... for targeting human breast cancer cells that overexpress SR-B1 receptors along with very low CD-36 receptor ...for breast cancer cells that do not express the SR-B1 ...when ... See full document
12
Clinicopathological Characteristics of Basal Type Breast Cancer in Triple Negative Breast Cancer
... Tissue samples were obtained from 365 patients diag- nosed with breast cancer from April 2004 to December 2010 at 1st Department of Surgery, Sapporo Medical University, Japan. Other background data for the ... See full document
5
<p>Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer</p>
... inhibiting cancer cell mitosis in ...in breast cancer patients during the disease progression and relapse in most of the ...(PI3Kgamma) activity is directly regulated by G βγ and Ras in the G ... See full document
11
Triple negative breast cancer: an Indian perspective
... biology. Triple negative cancer is commonly a prevalent phenotype in patients of central India accounting for 43% of all breast cancer with high grade large tumors and early local ... See full document
5
MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer
... in breast cancer, especially in triple- negative breast ...in breast cancer ...of breast cancer (Figure ...in triple-negative MDA-MB-231 and ... See full document
19
AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
... in breast cancer ...in breast cancer, as they regulate multiple cellu- lar processes to promote cancer growth, survival, and metastasis [50, ...the triple-negative subtype ... See full document
11
Related subjects